The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes
Autor: | David R. Sell, Vincent M. Monnier, Saul Genuth |
---|---|
Rok vydání: | 2016 |
Předmět: |
Glycation End Products
Advanced medicine.medical_specialty 030209 endocrinology & metabolism 030204 cardiovascular system & hematology Diabetic angiopathy Biochemistry Article Nephropathy 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Glycation Internal medicine Humans Medicine Pentosidine Molecular Biology Skin Subclinical infection Macrovascular disease Glycemic Type 1 diabetes business.industry Cell Biology medicine.disease Diabetes Mellitus Type 1 Endocrinology chemistry business Biomarkers Diabetic Angiopathies |
Zdroj: | Glycoconjugate Journal. 33:569-579 |
ISSN: | 1573-4986 0282-0080 |
DOI: | 10.1007/s10719-016-9702-2 |
Popis: | To date more than 20 glycation products were identified, of which ~15 in the insoluble human skin collagen fraction. The goal of this review is to streamline 30 years of research and ask a set of important questions: in Type 1 diabetes which glycation products correlate best with 1) past mean glycemia 2) reversibility with improved glycemic control, 2) cross-sectional severity of retinopathy, nephropathy and neuropathy and 3) the future long-term risk of progression of micro- and subclinical macrovascular disease. The trio of glycemia related glycation markers furosine (FUR)/fructose-lysine (FL), glucosepane and methylglyoxal hydroimidazolone (MG-H1) emerges as extraordinarily strong predictors of existing and future microvascular disease progression risk despite adjustment for both past and prospective A1c levels. X(2) values are up to 25.1, p values generally less than 0.0001, and significance remains after adjustment for various factors such as A1c, former treatment group, log albumin excretion rate, abnormal autonomic nerve function and LDL levels at baseline. In contrast, subclinical cardiovascular progression is more weakly correlated with AGEs/glycemia with X(2) values |
Databáze: | OpenAIRE |
Externí odkaz: |